Lantus (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Lantus drug offered from sanofi-aventis U.S. LLC. This Insulin [Chemical/Ingredient],Insulin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
NON-PROPRIETARY NAME: | insulin glargine |
SUBSTANCE NAME: | INSULIN GLARGINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-09-23 |
END MARKETING DATE: | 0000-00-00 |
Lantus HUMAN PRESCRIPTION DRUG Details:
Item Description | Lantus from sanofi-aventis U.S. LLC |
LABELER NAME: | sanofi-aventis U.S. LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100([iU]/mL) |
START MARKETING DATE: | 2009-09-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0088-2220_0dd5b537-70f4-45d3-8003-8ce600908e96 |
PRODUCT NDC: | 0088-2220 |
APPLICATION NUMBER: | NDA021081 |
Other INSULIN GLARGINE Pharmaceutical Manufacturers / Labelers: